Title for MeetingAbstracts
Alphabetical listing of titles
Activation of HIV-1 expression by bacteria associated with vaginosis.
Activation of HIV-1 LTR by a new GC box-binding transcription factor, BTEB.
Activation of HIV-1 provirus by HSV-1 infection proceeds through interaction between cellular and viral transactivators.
Activation of HIV-1 replication by hepatitis B virus.
Activation of human cytomegalovirus protease by dimerization.
ACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS BY LEISHMANIA DONOVANI IN HUMAN TONSILLAR TISSUE CULTURED EX VIVO.
Activation of human immunodeficiency virus in human myeloid cells by cocaine.
Activation of Human Immunodeficiency Virus-1 (HIV-1) by DNA demethylation.
Activation of human polyoma virus early gene promoters by HIV-1 transactivator Tat.
Activation of integrated HTLV-1 proviral gene expression from infected T cell lines.
Activation of latent HIV by spermatozoa.
Activation of leukemia inhibitory factor by HIV-1 Tat.
Activation of macaque lymphocyte subsets by SIVsmmPBj14.
Activation of methionine-enkephalin (MEK): enhancement of cytotoxic T-Cells in HIV+ patients.
Activation of modified anthrax toxin by HIV-1 infected cells.
Activation of modified anthrax toxin by HIV-1 protease.
Activation of monocytes by desialylation promotes infection with R5 HIV-1 BaL.
Activation of p38 MAP Kinase Is Required for Interleukin-6 Synthesis and NF-k B Transactivation Induced by Lipopolysaccharide (LPS) in Cultured Human Dermal Microvessel Endothelial Cells (HDMEC).
Activation of PBMN cells increases their susceptibility to infection by HIV-1 and upregulates a cell surface receptor for the anti-HIV-1 compound dextrin-2-sulphate.
Activation of Peripheral Blood Mononuclear Cells (PBMCs) by Gram-Positive (Gram+) Bacterial Walls Does Not Require the Presence of Wall-Attached Teichoic Acids.
Activation of the alternative complement pathway (AP) in different stages of HIV infection.
Activation of the anti-HIV agent 2',3'- dideoxy-2',3' didehydrothymidine (D4T) by human peripheral blood mononuclear cells (PBMC) in culture.
Activation of the ATR-initiated DNA Damage Signaling Pathway by HIV-1 Vpr.
ACTIVATION OF THE BLOOD-BRAIN BARRIER REQUIRES A CELLULAR AS WELL AS A VIRAL COMPONENT.
Activation of the cellular immune system in the CNS of HIV-1 infected individuals.
Activation of the cellular kinase PAK65 by SIV Nef is important for AIDS pathogenesis.
Activation of the DNA damage response by HIV-1 viral protein R.
Activation of the epidermal immune system in the course of HIV-infection.
Activation of the HIV and interferon regulatory elements in hematopoietic and epithelial cells.
Activation of the HIV promoter by radiation and drugs.